An interventional study of titrated anesthesia in Hypotension During Surgery, sponsored by Sixth Affiliated Hospital, Sun Yat-sen University. Recruiting at 2 sites in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-10.
Sponsored by Sixth Affiliated Hospital, Sun Yat-sen University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Hypotension with a site in China — 26 open to participants now, 29 under way, none of them phase 3. Hypotension · China.
Among the 59 studies in Hypotension with a site in China, this one is the 5th largest by planned enrollment of the 40 interventional ones that give a count, is one of 11 that started in 2026, is one of 26 with no phase, reaches primary completion later than 15 of the 28 other live ones, and was the 50th registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →26 of the 59 studies in Hypotension with a site in China are open now. Recruiting first, the newest first:
Beijing Tsinghua Chang Gung Hospital · Sites in China
Ages 18–85
Peking Union Medical College Hospital · Sites in China
Ages 65+
Peking Union Medical College Hospital · Sites in China
Ages 65+
Nanfang Hospital, Southern Medical University · Sites in China
Ages 65–90
Nanjing First Hospital, Nanjing Medical University · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 5 · Phase 4 9
First in 2013; this study’s year is marked. 11 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 86 across 593 interventional studies indexed under Hypotension.
Median enrollment 129 across the 40 interventional studies, 200 across the 19 observational. Of the 20 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 59 has an industry lead sponsor. The 10 most frequent:
Sixth Affiliated Hospital, Sun Yat-sen University is the lead sponsor of 217 studies on the registry; 111 are open to participants now.
Sixth Affiliated Hospital, Sun Yat-sen University has 2 studies filed under Hypotension — fewer than ten, so there is no comparison to draw.
11 of the studies in Hypotension with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07328958Sixth Affiliated Hospital, Sun Yat-sen UniversityEffect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial | 2026-12-30 |
| NCT07663695General Hospital of Ningxia Medical UniversityPropofol vs. Ciprofol for Anesthesia Induction in Frail Elderly Patients | 2026-12-31 |
| NCT07156474Lanyue ZhuImpact of Intraoperative Blood Pressure Components on Postoperative AKI: A Phenotype-Stratified Analysis | 2026-12-31 |
| NCT07239492Xuanwu Hospital, BeijingEfficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation | 2027-01-01 |
| NCT07949825The Fourth Affiliated Hospital of Zhejiang University School of MedicineEffect of Carotid Corrected Flow Time Guided Fluid Management on Post-Induction Hypotension in Elderly Patients | 2027-01-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 59 studies in Hypotension with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Elderly patients are frequently burdened with age-associated comorbidities and frailty, accompanied by physiological changes such as vascular stiffening, cardiac dysfunction, and impaired autonomic regulation. These factors not only increase the risk of adverse perioperative outcomes but also heighten sensitivity to anesthetic agents, making elderly patients particularly susceptible to anesthesia-related complications, especially hypotension. Consequently, optimizing anesthesia strategies for this high-risk population has become a critical goal in perioperative management.
Titrated anesthesia, which individualizes anesthetic drug delivery based on patient response to achieve predefined endpoints, offers a potential approach to mitigating anesthetic risks. Ciprofol, a novel intravenous anesthetic, has been associated with less hemodynamic suppression compared with traditional agents; however, higher single doses may still predispose patients to hypotension. Remifentanil, an ultra-short-acting opioid, exerts significant cardiovascular depressive effects, further contributing to perioperative hypotension.
It is hypothesized that titrated administration of anesthetic agents during both the induction and maintenance phases, compared with conventional fixed-dose protocols, may reduce the incidence of perioperative hypotension in elderly patients.
This study aims to investigate whether titrated anesthesia can provide more stable hemodynamic conditions during surgery and whether this approach is associated with improved postoperative recovery in elderly patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Child-Pugh class
A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in this group will undergo anesthesia induction and maintenance with ciprofol and remifentanil. Induction will be performed with intravenous bolus administration of ciprofol at a dose of 0.4 mg/kg and remifentanil at a dose of 1.2μg/kg, followed by a neuromuscular blocker to facilitate tracheal intubation. During surgery, anesthetic doses will be adjusted at the discretion of the anesthesiologist, based on the patient's physiological parameters and surgical conditions. BIS monitoring is applied and the screen remains visible to the anesthesiologist. However, ciprofol dose adjustments are made according to routine clinical judgement without reference to a prespecified BIS target or structured titration rule.
In this group, anesthesia induction is performed with continuous infusion of ciprofol until loss of consciousness (OAA/S score = 1). Remifentanil 1.2 μg/kg is then administered, followed by a neuromuscular blocker to facilitate tracheal intubation. After intubation, anesthesia was maintained with ciprofol (0.4-3 mg/kg/h) and remifentanil (0.01-0.5 µg/kg/min) until the end of surgery. Depth of anesthesia was adjusted intraoperatively to maintain BIS at approximately 50.
Drug: titrated anesthesia
Anesthesia induction and maintenance will be performed with ciprofol and remifentanil. During the entire procedure, infusion rates will be adjusted according to a target BIS value of approximately 50, with anesthetic dosing continuously modified in response to BIS monitoring. The attending anesthesiologist will titrate anesthetic delivery based on BIS guidance rather than routine clinical judgment alone.
Incidence of intraoperative hypotension.
Hypotension is defined as at least one episode of mean arterial pressure (MAP) \<65 mmHg sustained for at least 1 minute.
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
the time-weighted area under the curve (TWA) for MAP <65 mmHg during the anesthesia period
calculated as AUC / total time of anesthesia
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
cumulative dose of norepinephrine and the proportion of patients requiring vasoactive support;
the cumulative dose of norepinephrine administered intraoperatively (µg) and the proportion of patients who required any vasoactive medication (norepinephrine, dopamine, or ephedrine) during the anesthesia period.
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
the time-weighted area under the curve (TWA) for MAP <0.8 baseline during the anesthesia period
caculate as area under the curve / total anesthesia time
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
Time to first hypotension
The time to first hypotension during anesthesia
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
CI trend during anesthesia
CI data will be collected by the device and extracted for analysis.
Time frame: From induction of general anesthesia to the beginning of surgery, assessed intraoperatively for up to 2 hours.
The time periods with a higher incidence of hypotension between the two groups
The time is divided into four parts: induction period, post-induction period, surgical period, and early postoperative period
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
Total dose of ciprofol and remifentanil during surgery
The total doses of ciprofol and remifentanil administered per hour throughout the entire surgical procedure.
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
Whether blood pressure variability (CV) and the average rate of blood pressure variation (ARV) are different.
Both CV and ARV will be calculated using the formulas provided in the reference literature.
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
The incidence of severe intraoperative hypotension
Severe intraoperative hypotension is defined as MAP \< 55 mmHg
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
Time from discontinuation of anesthetic drugs to awakening.
Awakening is defined as the first eye opening in response to a verbal command.
Time frame: From discontinuation of anesthetic drugs to awakening, assessed up to 2 hours postoperatively.
the rate of postoperative delirium
Postoperative delirium is assessed using the Chinese version of the 3D-CAM scale. The Chinese version of the 3D-CAM has a sensitivity ranging from 84.6% to 87.2% and a specificity ranging from 96.7% to 97.4%. If a patient is admitted to the ICU, the CAM-ICU scale will be used to evaluate them for delirium.
Time frame: Postoperatively (4-6 hours), Day 1, Day 2, Day 3
Postoperative complications
The evaluation of postoperative complications will be conducted using Futier's classification system for postoperative complications, with the primary basis for assessment being medical record data and follow-up data.
Time frame: 30 days after the operation
All-cause mortality within 30 days after surgery.
All-cause mortality is defined as death from any cause occurring within 30 days following surgery.
Time frame: 30 days after operation
Hospital readmission within 30 days after surgery
Readmission is defined as any unplanned hospital admission occurring within 30 days after surgery.
Time frame: 30 days postoperatively.
The lowest MAP during anesthesia
The lowest MAP during anesthesia
Time frame: From induction of general anesthesia to the end of surgery, assessed intraoperatively for up to 6 hours.
Plan to share: Undecided
Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.
Of 213 non-industry interventional studies with no phase under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 11 months is close to that.
Counting every sponsor, half of 220 studies reached it within 12 months; a quarter within 6 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sixth Affiliated Hospital, Sun Yat-sen University →